Status:
UNKNOWN
Integrating Reminiscence Technology Into Exercise Programs in Subacute Care
Lead Sponsor:
Bruyère Health Research Institute.
Collaborating Sponsors:
Bruyere Academic Medical Organization
Conditions:
Rehabilitation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates the feasibility of a randomized controlled trial to evaluate the impact of motivating reminiscence-based therapy on exercise adherence, mood and physical health within a subacute ...
Detailed Description
Adherence to physical activity in older adults and those in a low-intensity rehabilitation program is important with respect to achieving the demonstrated benefits in mobility, physical function and o...
Eligibility Criteria
Inclusion
- Admitted to the LIR (Low-intensity rehabilitation) or CMP (complex medical program) unit/floor where the research study is being conducted. Of note, both units receive low intensity rehabilitation services at baseline.
- Participants capable of providing informed consent or have a SDM capable of providing consent on their behalf
- Sufficient visual abilities to observe images on the domed screen
- Able to comprehend and communicate in English or French
- Minimum height requirement of 5'2" or 157cm in order to successfully fit the BikeAround system's stationary bike.
Exclusion
- Physical limitations (as determined by the SVH healthcare/physiotherapy team) that prevent use of the jDome BikeAround. This includes:
- 1\) Inability to coordinate/move lower limbs effectively to complete pedaling task
- 2\) The pedaling exercise causes discomfort/pain greater than expected with physical activity
- 3\) Medical treatment prevents usage of the system (i.e. continuous ventilatory needs for patients admitted within the CMP unit)
- Cognitive impairment (as determined by the SVH healthcare/physiotherapy team) that prevent use of the jDome BikeAround, such as:
- 1\) Inability to sustain attention to focus on pedaling task
- 2\) Inability to follow one-step commands.
- Known behavioral abnormalities (e.g. overly aggressive behavior) that in the opinion of the clinical care team might impede any meaningful participation in the project
- Those who are in the opinion of, the attending physician or clinical team, too unwell to participate in the project
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05381571
Start Date
July 1 2023
End Date
April 1 2024
Last Update
February 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint-Vincent Hospital
Ottawa, Ontario, Canada, K1R 7A5